BioSpace News Archive

Skye advances multiple ascending dose arm of SBI-100 Ophthalmic Emulsion trial

Flavocure Biotech, Inc. (“Flavocure”), today announced that it has received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate a Phase I, first-in-human clinical study of Caflanone (FBL-03G) for the treatment of pancreatic cancer.

AIDS Healthcare Foundation supports an appeal by Médecins Sans Frontières urging Abbott Laboratories and Becton Dickinson to continue production of equipment and consumables for point-of-care CD4 machines. Both companies have announced that they will phase out the production of cartridges and devices over the coming years, including Abbott’s Pima CD4 analyzers, which AHF widely uses around the world.